FY4/24
Supplementary Materials

June 6, 2024

１．Consolidated Results■Year-on-Year(¥ million)

FY4/23
results

FY4/24
results

YoYchangeNet sales

358,742

399,824+41,082+11.5

Gross profit

53,69859,522+5,824+10.8% of net sales

15.0

14.9

37,69439,090+1,396

+3.7

10.5

9.8

16,004

20,432+4,428

+27.7

4.5

5.1

17,064

21,377+4,313

+25.3

4.8

5.3

9,234

11,401+2,167+23.5% of net sales

2.6

2.9

Earnings pershare(¥)

262.87324.64+61.77+23.5

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributableto owners of parent

YoYchange(%)

Figures in the table are rounded down

■Vs Plan(¥ million)

FY4/24
revised plan

Net sales

390,263

399,824+9,561+2.4

Gross profit

58,10659,522+1,416+2.4% of net sales

14.9

14.9

39,65639,090

(566)

(1.4)

10.2

9.8

18,45020,432+1,982

+10.7

4.7

5.1

19,34021,377+2,037

+10.5

5.0

5.3

10,00011,401+1,401+14.0% of net sales

2.62.9Earnings pershare(¥)

284.64324.64+40.00+14.1

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributableto owners of parent

FY4/24
results

Figures in the table are rounded down

-1-

Vs planchangeVs planchange(%)

２. Segment Information（Dispensing Pharmacy Business）■Year-on-Year(¥ million)

FY4/23
results

FY4/24
results

YoYchange

Net sales

321,577

357,571+35,994+11.2

Gross profit

39,77943,575+3,796+9.5% of net sales

12.4

12.2

16,55916,949+390+2.4

5.1

4.7

23,22026,625+3,405+14.7

7.2

7.4

24,13527,587+3,452

+14.3

7.5

7.7

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

YoYchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the consolidated statement of income■Vs Plan(¥ million)

FY4/24
revised plan

Net sales

349,100

357,571+8,471+2.4

Gross profit

42,68043,575+895+2.1% of net sales

12.2

12.2

17,16016,949(211)(1.2)

4.9

4.7

25,52026,625+1,105+4.3

7.3

7.4

26,39027,587+1,197

+4.5

7.6

7.7

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

FY4/24
results

Vs planchange

Vs planchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the consolidated statement of income-2-3. Segment Information（Cosmetic and Drug Store Business）■Year-on-Year(¥ million)

FY4/23
results

FY4/24
results

YoYchange

YoYchange(%)

Net sales

25,685

31,111+5,426+21.1

Gross profit

9,694

11,967+2,273+23.4% of net sales

37.7

38.5

8,521

8,913+392+4.6

33.2

28.6

1,172

3,054+1,882+160.6

4.6

9.8

1,214

3,096+1,882+155.0

4.7

10.0

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the consolidated statement of income■Vs Plan(¥ million)

FY4/24
revised planNet sales

29,50031,111+1,611+5.5

Gross profit

11,23011,967+737+6.6% of net sales

38.1

38.5

8,830

8,913+83+0.9

29.9

28.6

2,400

3,054+654+27.3

8.1

9.8

2,410

3,096+686+28.5

8.2

10.0

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

FY4/24
results

Vs planchange

Vs planchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the consolidated statement of income-3-4. Sales Verification■Dispensing Pharmacy Business (YoY）■Dispensing Pharmacy Business（Vs Plan）

Net sales

Net sales（%）

Average
Prescription
prescription
volume（%）
price

Average
Prescription
prescription
volumeprice

Same store (1,059)+7.0+5.6+1.4

Same store (1,059)+2.9+1.3+1.6

Store openings in theprevious year (132)+50.4+41.4+7.0

Store openings in theprevious year (132)+3.9+1.6+2.3

Total (1,231)+11.3+9.2＋2.0

Total (1,231)+2.4+0.8+1.6■Cosmetic and Drug Store Business（YoY）■Cosmetic and Drug Store Business (Vs Plan）

Net sales

Net sales（%）

Average
Number ofspending per
customers
customer（%）

Average
Number ofspending percustomers
customerSame store (68)+20.1

+11.3+8.0

Same store (68)+3.2(4.6)+8.2

Store openings in theprevious year (7)+103.7+100.3+1.7

Store openings in theprevious year (7)

+6.6

+5.8

+0.8

+21.1

+13.1

+7.1

Total (81)+5.5（3.7)+9.5

Total (81)-4-5. Consolidated Balance Sheet■Assets(¥ million)

End-FY4/22

End-FY4/23

End-FY4/24

Change59,729
10,11014,790100,765
17,512
8,581

46,79613,249
21,58698,305
21,407
10,602

48,611
15,852
24,645
110,743
27,122
10,207+1,815+2,603+3,059+12,438+5,715(395)

30,63639,45943,450+3,99136,352
41,2192,503
5,319
22,78546,44352,343
2,720
5,990
24,50744,066
51,242
3,345
6,403
25,186(2,377)(1,101)
+625
+413
+679

39,84041,641

43,973+2,332

Total assets

111,696
212,461

133,444
231,750

138,666
249,409+5,222+17,659

Figures in the table are rounded down

Change: End-FY4/24 compared with end-FY4/23

Cash on hand and in banks
Accounts receivable
Inventories
Total current assets
Buildings and structures, net
Land
Total property, plant andequipment
Goodwill
Total intangible fixed assets
Investments in securities
Deferred tax assets
Deposits and guarantees
Total investments and otherassets
Total fixed assets

Capital expenditures (Purchases of property, plant and equipment and intangible fixed assets + Deposits and guarantees)
totaled ¥ 15,268 million■Liabilities and Net Assets

End-FY4/22

End-FY4/23

End-FY4/24

ChangeTotal liabilities and net assets50,756
2,643
81,805
5,815
11,64593,45021,89420,50078,661
119,038
119,010
212,461

58,6983,670
92,986
5,021
12,218105,204
21,89420,50485,963
126,362
126,546
231,750

65,506
3,467
103,232
3,227
10,765
113,998
21,894
20,131
95,257
134,847
135,411249,409+6,808(203)+10,246(1,794)(1,453)+8,794(373)+9,294+8,485+8,865+17,659

Figures in the table are rounded down

Change: End-FY4/24 compared with end-FY4/23(¥ million)
Accounts payable
Short-term debt
Total current liabilities
Long-term debt
Total long-term liabilities
Total liabilities
Common stock
Capital surplus
Retained earnings
Total shareholders’ equity
Total net assets-5-6. FY4/25 Plan (Consolidated)(¥ million)

FY4/23
results

FY4/24
results

YoYchange（%）

YoYchangeFY4/25plan

Net sales

358,742

399,824

415,000+15,176+3.8

Gross profit

53,69859,522

59,671

+149

+0.3

15.0

14.9

14.4

37,69439,09041,871+2,781

+7.1

10.5

9.8

10.1

16,004

20,432

17,800(2,632)(12.9)

4.55.1

4.3

17,064

21,37718,500(2,877)(13.5)

4.8

5.3

4.5

Profit attributableto owners of parent

9,234

11,401

9,180(2,221)(19.5)% of net sales

2.6

2.9

2.2

Earnings pershare(¥)

262.87324.64262.33(62.31)(19.2)

Annual dividend (¥)

60.00

80.00

80.00

-

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Figures in the table are rounded down-6-

7. Transition of Store Openings■Number of Store Openings in Dispensing Pharmacy Business
FY4/16 FY4/17 FY4/18 FY4/19 FY4/20 FY4/21 FY4/22 FY4/23 FY4/24Organic

322725231415252719M&A110182111346142411421Total

881

1,066

1,029

1,132

1,088

1,065

1,099

1,2091,231■Number of Store Openings in Cosmetic and Drug Store Business
FY4/16 FY4/17 FY4/18 FY4/19 FY4/20 FY4/21 FY4/22 FY4/23 FY4/24Organic

594715111286Total

525248546369787881Inquiries related to this presentation should be addressed toAIN HOLDINGS INC.
Corporate Planning DivisionTEL(81)11-814-0010
FAX(81)11-814-5550
https://www.ainj.co.jp/corporate/
This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecasting statements
as to future results of operations. No forecast statement can be guaranteed andactual results of operations may differ from those projected.

-7-